These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
66 related items for PubMed ID: 21463688
1. Efficient one-step chromatographic purification and functional characterization of recombinant human Saposin C. Motta M, Tatti M, Martinelli S, Camerini S, Scarpa S, Crescenzi M, Tartaglia M, Salvioli R. Protein Expr Purif; 2011 Aug; 78(2):209-15. PubMed ID: 21463688 [Abstract] [Full Text] [Related]
2. The N370S (Asn370-->Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C. Salvioli R, Tatti M, Scarpa S, Moavero SM, Ciaffoni F, Felicetti F, Kaneski CR, Brady RO, Vaccaro AM. Biochem J; 2005 Aug 15; 390(Pt 1):95-103. PubMed ID: 15826241 [Abstract] [Full Text] [Related]
5. Direct AFM observation of saposin C-induced membrane domains in lipid bilayers: from simple to complex lipid mixtures. You HX, Qi X, Yu L. Chem Phys Lipids; 2004 Nov 15; 132(1):15-22. PubMed ID: 15530444 [Abstract] [Full Text] [Related]
6. Analysis of recombinant human saposin A expressed by Pichia pastoris. Yamada M, Inui K, Hamada D, Nakahira K, Yanagihara K, Sakai N, Nishigaki T, Ozono K, Yanagihara I. Biochem Biophys Res Commun; 2004 May 28; 318(2):588-93. PubMed ID: 15120640 [Abstract] [Full Text] [Related]
7. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor. Burkhardt JK, Hüttler S, Klein A, Möbius W, Habermann A, Griffiths G, Sandhoff K. Eur J Cell Biol; 1997 May 28; 73(1):10-8. PubMed ID: 9174667 [Abstract] [Full Text] [Related]
8. Reduced cathepsins B and D cause impaired autophagic degradation that can be almost completely restored by overexpression of these two proteases in Sap C-deficient fibroblasts. Tatti M, Motta M, Di Bartolomeo S, Scarpa S, Cianfanelli V, Cecconi F, Salvioli R. Hum Mol Genet; 2012 Dec 01; 21(23):5159-73. PubMed ID: 22949512 [Abstract] [Full Text] [Related]
9. Non-neuronopathic Gaucher disease due to saposin C deficiency. Tylki-Szymańska A, Czartoryska B, Vanier MT, Poorthuis BJ, Groener JA, Ługowska A, Millat G, Vaccaro AM, Jurkiewicz E. Clin Genet; 2007 Dec 01; 72(6):538-42. PubMed ID: 17919309 [Abstract] [Full Text] [Related]
10. Recombinant expression and affinity purification of a novel epididymal human sperm-binding protein, BSPH1. Lefebvre J, Boileau G, Manjunath P. Mol Hum Reprod; 2009 Feb 01; 15(2):105-14. PubMed ID: 19091820 [Abstract] [Full Text] [Related]
11. Structural changes in a binary mixed phospholipid bilayer of DOPG and DOPS upon saposin C interaction at acidic pH utilizing 31P and 2H solid-state NMR spectroscopy. Abu-Baker S, Qi X, Newstadt J, Lorigan GA. Biochim Biophys Acta; 2005 Nov 10; 1717(1):58-66. PubMed ID: 16289479 [Abstract] [Full Text] [Related]
14. The effects of chemically synthesized saposin C on glucosylceramide-β-glucosidase. Yoneshige A, Muto M, Watanabe T, Hojo H, Matsuda J. Clin Biochem; 2015 Nov 10; 48(16-17):1177-80. PubMed ID: 26068040 [Abstract] [Full Text] [Related]
15. Characterization of human saposins by NMR spectroscopy. John M, Wendeler M, Heller M, Sandhoff K, Kessler H. Biochemistry; 2006 Apr 25; 45(16):5206-16. PubMed ID: 16618109 [Abstract] [Full Text] [Related]
16. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli. Jaiswal S, Khanna N, Swaminathan S. Protein Expr Purif; 2004 Jan 25; 33(1):80-91. PubMed ID: 14680965 [Abstract] [Full Text] [Related]
17. Further studies on the reconstitution of glucosylceramidase activity by Sap C and anionic phospholipids. Salvioli R, Tatti M, Ciaffoni F, Vaccaro AM. FEBS Lett; 2000 Apr 21; 472(1):17-21. PubMed ID: 10781797 [Abstract] [Full Text] [Related]